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A B S T R A C T
Background and Aims: In hereditary hemochromatosis, iron deposition in the liver parenchyma may lead to
ﬁbrosis, cirrhosis and hepatocellular carcinoma. Most cases are ascribed to a common mutation in the HFE
gene, but the extent of clinical expression is greatly inﬂuenced by the combined action of yet unidentiﬁed genetic
and/or environmental modifying factors. In mice, transcription factor NRF2 is a critical determinant of
hepatocyte viability during exposure to acute dietary iron overload. We evaluated if the genetic disruption of
Nrf2 would prompt the development of liver damage in Hfe-/- mice (an established model of human HFE-
hemochromatosis).
Methods: Wild-type, Nrf2-/-, Hfe-/- and double knockout (Hfe/Nrf2-/-) female mice on C57BL/6 genetic
background were sacriﬁced at the age of 6 (young), 12–18 (middle-aged) or 24 months (old) for evaluation of
liver pathology.
Results: Despite the parenchymal iron accumulation, Hfe-/- mice presented no liver injury. The combination of
iron overload (Hfe-/-) and defective antioxidant defences (Nrf2-/-) increased the number of iron-related
necroinﬂammatory lesions (sideronecrosis), possibly due to the accumulation of toxic oxidation products such
as 4-hydroxy-2-nonenal-protein adducts. The engulfment of dead hepatocytes led to a gradual accumulation of
iron within macrophages, featuring large aggregates. Myoﬁbroblasts recruited towards the injury areas
produced substantial amounts of collagen ﬁbers involving the liver parenchyma of double-knockout animals
with increased hepatic ﬁbrosis in an age-dependent manner.
Conclusions: The genetic disruption of Nrf2 promotes the transition from iron accumulation (siderosis) to liver
injury in Hfe-/- mice, representing the ﬁrst demonstration of spontaneous hepatic ﬁbrosis in the long term in a
mouse model of hereditary hemochromatosis displaying mildly elevated liver iron.
1. Introduction
HFE-associated hereditary hemochromatosis (HH) is a common
autosomal disease characterized by excessive intestinal absorption of
dietary iron and its accumulation in tissues, with secondary organ
damage ascribed to oxidative stress [1]. The liver, being the main body
iron reservoir, is particularly exposed to iron toxicity [2]. Thus, HH
patients have increased risk of hepatic ﬁbrosis, cirrhosis and hepato-
cellular carcinoma, with symptoms often starting in the fourth decade
of life [1]. While most HH patients are homozygous for the p.C282Y
variant of the HFE gene, there is great phenotypic variability among
C282Y homozygotes concerning both the degree of iron loading and the
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risk of liver disease [3,4]. Organ disease develops only in a minority of
C282Y homozygotes, most commonly as a result of alcohol toxicity,
obesity-related steatosis, diabetes but also due to other genetic/
environmental modifying factors that are still unidentiﬁed [1,3–7].
The Hfe-/- mouse develops spontaneous parenchymal iron overload
similar to human HH [8]. Despite the increasing hepatic iron overload,
Hfe-/- mice present no hepatic ﬁbrosis or cirrhosis [9,10], which
suggests the existence of eﬃcient adaptive mechanisms that protect
mice from the noxious eﬀect of iron overload.
The transcription factor NRF2 (Nfe2l2/Nrf2) plays a key role in the
adaptation to oxidative/electrophilic stress by regulating the transcrip-
tional induction of a series of cytoprotective genes including antiox-
idant and xenobiotic conjugating enzymes, ubiquitin/proteasomes,
chaperones and heat-shock proteins [11]. Several studies have demon-
strated that livers of Nrf2-/- mice are more susceptible to oxidative/
electrophilic stress than those of wild-type mice [12,13], and NRF2 is
increasingly regarded as an important modiﬁer of chronic liver diseases
[14]. Recently, we have reported that iron activates NRF2 in mouse
hepatocytes and that NRF2 is important for the viability of hepatocytes
during exposure to acute dietary iron overload [15]. To test the
hypothesis that NRF2-mediated resistance to oxidative/electrophilic
stress may be a modiﬁer of disease progression in HFE-HH, we aimed
to evaluate if the genetic suppression of Nrf2 would predispose the
Hfe-/- mouse to spontaneous liver damage. For that purpose, a double
knockout (Hfe/Nrf2-/-) was generated by crossing Hfe-/- and Nrf2-/-
mice on C57BL/6 genetic background. Since the disease has a late
onset in humans, we evaluated the eﬀect of each genotype on liver
pathology and antioxidant defenses in mice at the ages of 6 (young),
12–18 (middle-aged) and 24 months (old).
2. Materials and methods
2.1. Reagents
All chemicals and reagents were purchased from Sigma-Aldrich
(Munich, Germany), unless otherwise stated.
2.2. Animals
To generate Hfe and Nrf2 compound homozygous mutant animals,
Hfe-null mice [8] were mated with Nrf2-null mice [16] to generate
double heterozygous mutant mice (Hfe+/- and Nrf2+/-) on C57BL/6
genetic background. These mice were then intercrossed to generate
either compound homozygous mutant mice (Hfe/Nrf2-/-) or ones with
various other combinations of mutant and wild-type alleles.
Polymerase chain reaction (PCR) analysis was performed to determine
the mouse genotype. Primers are listed in Supplementary Table 1.
Animals were housed at the Instituto de Biologia Molecular e
Celular animal facility in a temperature and light-controlled environ-
ment, with free access to standard rodent chow (4RF21 containing
480 mg/kg iron sulfate heptahydrate, Mucedola, Milan, Italy) and
water. Young (6 months old), middle-aged (12–18 months old) and
old (24 months old) female mice were sacriﬁced for tissue collection. In
each genotype, the middle-aged group comprised an equal number of
individuals at 12 and 18 months of age. Blood was obtained by retro-
orbital bleeding under terminal anesthesia with isoﬂurane. Liver
fragments were snap-frozen in liquid nitrogen and stored at −80 °C
for subsequent RNA and antioxidant enzyme activity analysis. All
animals received humane care according to the criteria outlined by the
Federation of European Laboratory Animal Science Associations for
the care and handling of laboratory animals (EU Directive 2010/63/
EU); experimental procedures were approved by the Instituto de
Biologia Molecular e Celular Animal Ethics Committee.
2.3. Histology and immunohistochemistry
Tissue samples were ﬁxed in neutral formalin 10% and embedded
in paraﬃn. Following deparaﬃnization with xylene and hydration by a
passage through a grade of alcohols, 3 µm-thick sections were stained
with hematoxylin-eosin, Perls’ Prussian blue reaction for ferric iron
and Sirius red using standard procedures. Histological iron grading
was performed using the grading system of Deugnier et al. [17], which
takes into account the size of iron deposits, as well as their cellular and
lobular location, leading to three scores: hepatocytic (ranging 0–36),
sinusoidal (ranging 0–12) and portal (ranging 0–12). All slides
(stained with Perls' method) were examined by the same observer, in
a blind manner (i.e. with no previous knowledge of the animals'
genotypes). Evaluation of necroinﬂammatory lesions (sideronecrosis)
was performed according to Deugnier et al. [17]. Staging of liver
ﬁbrosis was performed by an anatomic pathologist (JML) according to
Kleiner et al. [18], as follows: 0) none; 1) mild perisinusoidal or
periportal; 2) perisinusoidal and portal/periportal; 3) bridging ﬁbrosis;
and 4) cirrhosis. The quantiﬁcation of collagen type I (yellow-orange
birefringence) in liver sections stained with Sirius red was performed
under polarized light and expressed as the percentage of ﬁbrotic area.
Digital images of 3 diﬀerent ﬁelds at ×100 magniﬁcation were analyzed
using ImageJ software (available at http://rsbweb.nih.gov/ij/index.
html) to assess the percentage of stained area compared with the total
evaluated liver area.
Fragmented DNA was detected through TdT-mediated dUTP nick-
end labeling (TUNEL) staining as described by Silva-Gomes et al.[15].
For the detection of F4/80, samples were blocked with 5% bovine
serum albumin and 0.05% Tween 20 in phosphate buﬀer and incubated
with rat anti-F4/80 (Serotec, Oxford, UK), followed by goat anti-rat
IgG AlexaFluor 647 (Life Technologies, Carlsblad, CA, USA). For the
detection of alpha-smooth muscle actin (α-SMA), samples were
permeabilized in 0.2% Triton X-100 in phosphate buﬀer, then sub-
jected to antigen retrieval in microwave with citrate buﬀer, blocked
with mouse-on-mouse blocking solution (Vector, Burlingame, CA,
USA) and incubated with mouse anti-α-SMA, followed by goat anti-
mouse IgG AlexaFluor488 (Life Technologies, Carlsblad, CA, USA). Cell
nuclei were stained with 4′,6-diamidino-2-phenylindole. Samples were
Table 1
Body weight, relative liver weight and serum ALT.
Body weight Relative liver weight Serum ALT
Wild-type N (g) (%) (U/L)
Young 8 24.2 ± 1.9 4.5 ± 0.3 26.4 ± 3.0
Middle-aged 15 30.6 ± 3.6 4.7 ± 0.7 33.7 ± 9.7
Old 9 33.3 ± 3.6 4.4 ± 0.5 27.0 ± 4.0
Nrf2-/-
Young 8 22.9 ± 3.1 3.5 ± 0.7a 25.8 ± 5.2
Middle-aged 15 30.5 ± 3.5 4.1 ± 0.4a 34.7 ± 6.9
Old 8 29.4 ± 5.1a 4.0 ± 0.5 32.8 ± 6.4
Hfe-/-
Young 10 24.5 ± 1.6 3.9 ± 0.4 25.2 ± 3.1
Middle-aged 14 30.8 ± 3.5 4.5 ± 0.4 29.8 ± 7.4
Old 8 38.9 ± 4.5a 3.9 ± 0.6 31.5 ± 4.3
Hfe/Nrf2-/-
Young 6 24.1 ± 1.6 4.0 ± 0.8 27.7 ± 3.8
Middle-aged 11 26.8 ± 2.4a 3.8 ± 0.8a 35.6 ± 10.3
Old 9 26.5 ± 1.6a 3.9 ± 0.6 45.3 ± 24.5a
a p < 0.05 vs. age-matched wild-type mice. ALT, alanine aminotransferase.
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analyzed in a wide ﬁeld ﬂuorescence microscope (Zeiss AxioImager Z1,
Carl Zeiss, Jena, Germany).
2.4. Transmission electron microscopy
Liver tissue samples were ﬁxed and embedded in Epon as described
by Silva-Gomes et al. [15]. Semithin sections (approximately 0.5 µm
thick), stained with toluidine blue and methylene blue, were used to
search for areas of interest. Ultrathin sections, either unstained or
stained with uranyl acetate and lead citrate, were evaluated by electron
microscopy as described by Silva-Gomes et al. [15]. Elemental analysis
was performed on a JEM 1400 electron microscope (Jeol, Tokyo,
Japan) ﬁt with a Schottky ﬁeld emission gun, a high-angle annular dark
ﬁeld detector and an X-MAX 80 mm2 ultrathin window energy-
dispersive X-ray spectroscopy detector (Oxford Instruments, Oxford,
UK). Spectra were collected from 3 distinct electron-dense and 3
distinct electron-lucent areas at a 20.2° tilt angle with a stationary
electron probe in scanning transmission electron microscope mode (at
an accelerating voltage of 80 kV).
2.5. Tissue iron quantiﬁcation
Non-heme iron content in tissue samples was measured as de-
scribed by Silva-Gomes et al. [15].
2.6. Hydroxyproline content
Liver samples (10 mg) were homogenized in ultrapure water and
hydroxyproline was quantiﬁed using the Hydroxyproline assay kit
(Sigma-Aldrich).
2.7. Assessment of total glutathione content and glutathione-S-
transferase activity
Liver samples were collected, homogenized in cold phosphate
buﬀer (25 mM KH2PO4, 30 mM Na2HPO4·2H2O and 0.1% Triton X-
100, pH 7.0) and protein content was quantiﬁed using the Bio-Rad DC
protein assay kit (Hercules, CA, USA). Homogenates were centrifuged
(16,000g, 10 min, 4 °C) and the supernatants were aliquoted and
stored at −80 °C. Glutathione-S-transferase activity and the total
glutathione content were determined as described by Assunção et al.
[19].
2.8. Western blotting
Liver samples were homogenized in lysis buﬀer (300 mM sodium
chloride, 50 mM Tris-HCl pH 7.4, 1% Triton X-100) containing
protease inhibitors. Total protein content of lysates was measured
using the RC/DC Protein Assay (Bio-Rad, Hercules, CA) and 30 µg
resolved by electrophoresis on 12% SDS-polyacrylamide gels. Proteins
were then transferred to 0.45 µm nitrocellulose Hybond-C Extra
membranes (GE Healthcare, Portugal). After blocking with 5% dry
milk in Tris-buﬀered saline containing 0.05% Tween 20 (TBS-T) for
1 h, membranes were incubated overnight with anti 4- hydroxynonenal
rabbit antiserum clone HNE11-S (1:500; Alpha Diagnostic
International, Santo Antonio, Texas, USA) or for 1 h with rabbit
polyclonal antibody anti-p62 (SQSTM1) from MBL (1:1000; Nagoya,
Japan), followed by a horseradish peroxidase-conjugated sheep anti-
rabbit IgG (Life Technologies, Carlsblad, CA, USA) for 1 h at room
temperature. After washing with TBS-T, signal was developed with a
chemiluminescence substrate (Millipore, Billerica, MA, USA) and the
blots exposed to CL-X Posure ﬁlms (Pierce, Rockford, IL). For normal-
ization of protein loading, blots were stripped and reprobed with a
rabbit antibody against β-actin (Abcam, Cambridge, UK).
2.9. Real-time reverse-transcription-PCR
RNA isolation and analysis of gene expression were performed as
described by Silva-Gomes et al. [15]. The quantity of genes involved in
iron homeostasis (hepcidin antimicrobial peptide, Hamp), antioxidant
response [NAD(P)H dehydrogenase, quinone 1, Nqo1; glutathione S-
transferase, alpha 1, Gsta1] and ﬁbrogenesis (collagen, type I, alpha 1,
Col1a1; tissue inhibitor of metalloproteinase 1, Timp1) was normalized
against the quantity of the endogenous control gene (hypoxanthine
guanine phosphoribosyl transferase,Hprt). Primer sequences are listed
in Supplementary Table 1.
2.10. Serum parameters
Serum biochemical markers of iron metabolism and liver toxicity
were analyzed as described by Silva-Gomes et al. [15].
2.11. Statistical analysis
All data were statistically analyzed by using the GraphPad Prism
6.07 software (GraphPad Software, CA, USA) and the averaged values
are presented as mean and standard deviation. Diﬀerences among
multiple group means were compared by one-way or two-way analysis
of variance (when testing for mouse genotype alone or mouse genotype
vs. age, respectively) with Dunnet's multiple comparison test. The
association between variables was assessed using Pearson correlation.
Statistical signiﬁcance was assumed at p < 0.05.
3. Results
Hfe/Nrf2+/- mice gave birth to viable double knock-outs (Hfe/
Nrf2-/-) according to Mendelian frequencies (data not shown). Young
Hfe/Nrf2-/- adults were apparently healthy and fertile. At 6 months of
age, their average body weight was not diﬀerent from age-matched
wild-types or single knockouts. From middle-age on, however, they
weighed signiﬁcantly less than age-matched wild-types. This was in
contrast with Hfe-/- animals, which sustained gain weight until
sacriﬁce, compared to wild-type counterparts (Table 1).
Concerning the liver, Hfe/Nrf2-/- animals presented a trend for
lower relative liver weight, which reached statistical signiﬁcance only in
the middle-aged group (Table 1). Serum alanine aminotransferase
activity was mildly increased in old Hfe/Nrf2-/- mice (Table 1).
Nonetheless, livers of old Hfe/Nrf2-/- mice were macroscopically
distinct upon dissection (Fig. 1A). Whereas wild-type and single
knock-out livers displayed smooth surface with perceptible individual
lobes, old Hfe/Nrf2-/- livers presented an irregular surface and a
contracted, distorted and nodular appearance, consistent with ﬁbrosis.
Since the activation of ﬁbrogenesis is a major consequence of par-
enchymal iron overload in the livers of HFE-HH patients [4], we
evaluated the presence of ﬁbrosis by quantifying the amount of
hydroxyproline and the expression of pro-ﬁbrotic genes in the liver of
old mice. In line with the macroscopic features, Hfe/Nrf2-/- livers
contained signiﬁcantly higher hydroxyproline content (Fig. 1B) and
mRNA expression of Col1a1 and Timp1 compared with age-matched
wild-types (Figs. 1C and D). Fibrosis was further assessed in paraﬃn-
embedded liver sections of mice of all age groups using Sirius red stain.
In wild-type and single knock-out livers, collagen ﬁbers were usually
restricted to the blood vessels encircling connective tissue (Fig. 2A). In
Hfe/Nrf2-/- livers, collagen ﬁbers were more abundant, encompassing
both periportal and pericellular ﬁbrosis (Fig. 2A). Quantiﬁcation of
ﬁbrotic area revealed that ﬁbrosis was present in young Hfe/Nrf2-/-
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mice, preceding the loss of body weight (Fig. 2B). The staging of
ﬁbrosis revealed its progression with ageing; the occurrence of bridging
ﬁbrosis was observed in Hfe/Nrf2-/- animals at old age (Fig. 2C).
Cirrhosis was not detected.
Liver ﬁbrosis can be triggered by diﬀerent stimuli and is important
in several pathologies that lead to liver failure [20]. To investigate
whether iron was implicated in the etiopathogenesis of liver ﬁbrosis in
the present experimental model, we assessed systemic and hepatic iron
overload in mice of diﬀerent genotype and age groups. We found no
signiﬁcant diﬀerences when comparing the levels of serum iron,
transferrin saturation or liver non-heme iron of Nrf2-/- mice with
those of age-matched wild-types (Figs. 3A–C). As observed in un-
treated HH patients, serum iron (Fig. 3A) and transferrin saturation
(Fig. 3B) were signiﬁcantly raised in Hfe-/- mice of all ages. Liver iron
stores were also signiﬁcantly higher, increasing along animal ageing
(Fig. 3C). In HH, increased iron absorption is believed to be caused by
insuﬃcient hepcidin expression [4]. In line with a previous report from
Ahmad et al. [21], the lack of HFE associated with low steady-state
levels of hepatic Hamp mRNA expression, as expected for the amount
of iron accrued in the liver (Fig. 3D). Serum iron (Fig. 3A) and
transferrin saturation (Fig. 3B) were also signiﬁcantly increased in
young and middle-aged Hfe/Nrf2-/- mice, but not in old animals.
Nonetheless, Hfe/Nrf2-/- mice revealed raised liver iron stores
throughout life, like their Hfe-/- siblings (Fig. 3C), possibly related to
inadequate hepatic Hamp expression (Fig. 3D). Perls method was
performed to evaluate the amount of iron in liver tissue (Fig. 4A).
Histological grading revealed that in wild-type and in Nrf2-/- mice iron
was faint or absent (Fig. 4B). In Hfe-/- mice, iron was almost restricted
to the liver parenchyma (Fig. 4B), with a decreasing gradient from the
periportal to the centrilobular zones (Fig. 4A). In Hfe/Nrf2-/- mice,
iron was detected ﬁrstly in periportal hepatocytes, but with age there
was a steady iron accumulation in sinusoidal cells (Fig. 4B). From
middle-age on, Hfe/Nrf2-/- livers displayed mixed (parenchymal and
mesenchymal) liver iron overload pattern, as observed in secondary
hemosiderosis (Fig. 4A). Electron microscopy disclosed accumulation
of electron-dense material, consistent with iron, within pericanalicular
hepatocyte lysosomes (Supplementary Figure 1A), as reported in
human HH [17], but also the presence of ferritin and hemosiderin
/
wt
Nrf2 -/-
Hfe -/-
Hfe/Nrf2 -/-
0
1
2
3
4
5
C
ol
1 
A
1 
m
R
N
A
*
n.s.n.s.
0
1
2
3
4
5
Ti
m
 p
1 
m
R
N
A
*
n.s.
n.s.
0.000
0.001
0.002
0.003
0.004
H
yd
ro
xy
 p
ro
lin
e 
(m
g/
m
g 
pr
ot
ei
n)
*
n.s.
n.s.
Fig. 1. Liver macroscopy and ﬁbrosis markers in old mice. (A) Macroscopic appearance of livers of representative old mice demonstrating the irregular surface and the
contracted, distorted and nodular appearance of the Hfe/Nrf2-/- livers (Bar=1 cm). (B) Hydroxyproline content of mouse livers, N=4. (C) and (D) Expression of Col1a1 and Timp1
mRNA in mouse livers, N=7–9. *, p < 0.05 vs. age-matched wild-type mice; n.s., p > 0.05 vs. age-matched wild-type mice.
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within non-hepatocyte cells (Supplementary Figure 1B), as described
by others [22]. Large aggregates of non- parenchymal cells rich in a
granular yellow-brown pigment strongly positive with Perls method
were observed (Fig. 4A). Energy-dispersive X-ray spectroscopy ele-
mental analysis conﬁrmed that the electron-dense granules of non-
parenchymal cells were iron- and oxygen-rich, consistent with ferric
oxide components of hemosiderin (Supplementary Figure 1C). By
immunoﬂuorescence, we observed that these non- parenchymal cells
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Fig. 2. Histological evaluation of liver ﬁbrosis. (A) Sirius red staining for collagen in paraﬃn-embedded liver sections. Images are representative of N=6–10. Bar=500 µm. (B)
Quantiﬁcation of ﬁbrotic area in mouse livers of all ages and genotypes, N=6–10. (C) Staging of liver ﬁbrosis in wt (circles), Nrf2-/-(squares), Hfe-/- (triangles) and Hfe/Nrf2-/- (inverted
triangles) mice of all age groups. *, p < 0.05 vs. age-matched wild-type mice; n.s., p > 0.05 vs. age-matched wild-type mice.
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contained also autoﬂuorescent material (lipofuscin-type) and displayed
macrophage immunophenotype (F4/80+) (Fig. 4C). Hence, Hfe/Nrf2-/-
livers contained a signiﬁcantly higher number of iron-rich macro-
phages than wild-types (Fig. 4D).
Liver reticuloendothelial system cells may become iron-laden
through phagocytosis of erythrocytes and iron-overloaded apoptotic
hepatocytes. Since we have recently reported that Nrf2-/- hepatocytes
are more susceptible to the injury of dietary iron [15], we searched for
evidence of hepatocellular injury in Hfe/Nrf2-/- mice. Notably, we
found bonaﬁde necroinﬂammatory foci comprising histiocytes, side-
rophages, hepatocyte necrosis and apoptotic bodies (Fig. 5A). Discrete
features of hepatocyte apoptotic cell death included cytoplasmic
shrinkage and nuclear chromatin condensation and fragmentation
(Fig. 5A). The frequency of the necroinﬂammatory foci increased with
age (Fig. 5B), in parallel with the increase of TUNEL-positive hepato-
cytes (Fig. 5C). Remarkably, the progression of these two features with
age matched the increase in the number of iron-rich macrophages
(Fig. 4D) and in the percentage of ﬁbrotic area (Fig. 2B), indicating that
reticuloendothelial iron loading and ﬁbrosis were triggered by iron-
related necroinﬂammation (sideronecrosis). This assumption is sup-
ported, at least in part, by the analysis of liver histology. Indeed, Hfe/
Nrf2-/- mice displayed iron overload of non-hepatocyte cells located in
the sideronecrosis foci, consistent with phagocytosis of dead hepato-
cytes by reticuloendothelial cells (Figs. 6A and 7A). Additionally, the
resolution of the necroinﬂammatory foci paralleled the gradual in-
crease of collagen ﬁbers (Fig. 6A), and collagen accumulation arose in
areas of reticuloendothelial iron loading (Fig. 6B), as highlighted by the
Sirius red and Perls method features. Hepatic stellate cells (HSCs) are
considered the main ﬁbrogenic cell type in the liver, and are respon-
sible for the production of collagen and other types of extracellular
matrix [23]. By transmission electron microscopy, we observed the
presence of activated-type HSC nearby the sideronecrosis foci
(Fig. 7A), and in the proximity of aggregates of phagocytes that had
engulfed leftovers of all forms of necrosis/apoptosis, including lipo-
fuscin-containing vesicles (residual bodies), electron-dense granules
consistent with hemosiderin, and cell debris (Fig. 7B). By immuno-
ﬂuorescence, we established the presence of well diﬀerentiated myoﬁ-
broblasts (expressing alpha-smooth muscle actin, α-SMA) contiguous
with collagen bundles close to the large aggregates of lipofuscin/
hemosiderin-rich macrophages (Fig. 7C). To analyse quantitatively
the association between sideronecrosis and ﬁbrosis, we pooled middle-
aged and old animals of all genotypes, and for each individual we
plotted the percentage of ﬁbrotic area against the hepatic non-heme
iron concentration or the number of necroinﬂammatory foci. Fig. 8A
shows that ﬁbrosis correlated with the non-heme hepatic iron content
in the pooled population (r=0.5001, p < 0.0001), but the strength of the
correlation was lowered probably by the fact that Hfe-/- mice are
somehow protected from ﬁbrosis. On the other hand, a stronger
correlation was found between liver ﬁbrosis and the number of
necroinﬂammatory foci (r=0.8472, p < 0.0001) (Fig. 8B).
The data presented so far show that, unlike Hfe-/- counterparts,
Hfe/Nrf2-/- livers displayed sideronecrosis-associated ﬁbrosis, which
cannot be attributed only to the iron loading. Hepatic iron toxicity is
generally considered to be due to increased oxidative stress leading to
hepatocellular death (sideronecrosis) [2]. We hypothesized that the
genetic disruption of Nrf2 rendered Hfe/Nrf2-/- hepatocytes more
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prone to iron-induced oxidative/electrophilic stress. Thus, a series of
parameters associated with oxidative/electrophilic stress was evaluated
in middle-aged livers. In line with our hypothesis, the mRNA expres-
sion of the prototypical NRF2 target genes Nqo1 (Fig. 9A) and Gsta1
(Fig. 9B), and the enzymatic activity of glutathione-S-transferase
(Fig. 9C) were signiﬁcantly lower in middle-aged Nrf2-/- and Hfe/
Fig. 4. Hepatic tissue iron distribution. (A) Perls’ prussian blue stain displaying distinct hepatic iron overload in Hfe-/- and Hfe/Nrf2-/- mice of all age groups. Insets show iron
overload in periportal hepatocytes. Bar=500 µm or 50 µm (insets). (B) Histological iron grading, N=6–12. (C) Immunoﬂuorescence micrograph of a liver section from a middle-aged
Hfe/Nrf2-/- mouse stained for F4/80 depicting a large aggregate of macrophages (F4/80+ cells) containing autoﬂuorescent material. Bar=20 µm. (D) Quantiﬁcation of iron-rich
macrophages in liver sections, N=5–11. *, p < 0.05 vs. age-matched wild-type mice; n.s., p > 0.05 vs. age-matched wild-type mice.
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Nrf2-/- mouse livers compared with age-matched wild-type animals.
Levels of total glutathione, the major hepatocellular antioxidant, were
also signiﬁcantly lower in Nrf2-/- and Hfe/Nrf2-/- livers than in wild-
type (Fig. 9D). The alterations of these antioxidant markers were
expected to cause increased oxidative/electrophilic stress and cell
damage. We estimated the amount of 4-hydroxy-2-nonenal (4-HNE),
a cytotoxic aldehyde product of the peroxidation of polyunsaturated
fatty acids that is able to diﬀuse across membranes and bind covalently
to functional proteins [24]. According to our hypothesis, higher levels
of 4-HNE-protein adducts were present in liver homogenates of Hfe/
Nrf2-/- mice compared with wild-type counterparts (Fig. 9E). Likewise,
the expression of p62/SQSTM1 protein, which is known to be
increased in chronic liver diseases in response to oxidative stress and
to the accumulation of toxic protein aggregates [25], was signiﬁcantly
greater in Hfe/Nrf2-/- livers (Fig. 9F). Taken together, the data
presented above indicate that the accumulation of toxic oxidation
products, such as 4-HNE, likely contributed to hepatocellular injury
and concomitantly to liver ﬁbrosis in the present study.
4. Discussion
In human HH, the long-term deposition of iron in the liver can lead
to organ damage, including hepatic ﬁbrosis and cirrhosis. The devel-
opment of hepatic injury in HH is highly variable and cannot be
ascribed solely to the severity of iron overload. Clinical cofactors
inﬂuence disease progression and genetic factors may also play a role
[1,3–7]. In rodents, the ability of iron to stimulate the progression of
experimentally-induced hepatic ﬁbrosis has been reported; alcoholic
liver ﬁbrosis is potentiated by dietary iron [26] and carbon tetrachlor-
ide-induced liver ﬁbrogenesis is exacerbated in mice fed carbonyl iron
[27] and in hemojuvelin knockout mice [28]. Conversely, an iron-
deﬁcient diet attenuates the development of liver ﬁbrosis after treat-
ment of rats with thioacetamide or bile-duct ligation [29]. Yet, hepatic
ﬁbrosis and cirrhosis have not been observed in the mouse models of
HFE-HH [9,10] and hemojuvelin-associated HH [30]; this evokes the
existence of eﬃcient adaptive mechanisms that render the mouse liver
able to bear the increased iron toxicity. Such unidentiﬁed mechanisms
may also be implicated in the low penetrance of the HFE mutation in
humans.
Transcription factor NRF2 is a master regulator of cellular detox-
iﬁcation responses and redox status [13] that protects mice against
hepatotoxin-induced ﬁbrosis [12]. We have previously reported the
development of extensive hepatocyte necrosis in Nrf2-null mice fed an
excessive amount of dietary iron [15]; this occurred in the absence of
ﬁbrosis, probably because the iron overload (equivalent to the hepatic
iron stores of middle-aged Hfe-/- mice) was induced over a short period
of time (2 weeks). In the present study, we used the Hfe-/- mouse, a
model of human HFE-HH that displays several features of human
C282Y homozygotes: mild parenchymal iron overload with decreasing
hepatocytic gradient from the periportal to centrilobular zones, con-
sistent with increased intestinal absorption of iron [17]; insuﬃcient
hepcidin production in spite of excessive iron deposition in the hepatic
parenchyma [31]; elevated serum iron and transferrin saturation [32];
and normal alanine aminotransferase [33]. We established, so far for
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the ﬁrst time, that the genetic disruption of Nrf2 in the Hfe-/- mouse
increased hepatocyte apoptosis/sideronecrosis, in association with foci
of inﬂammation, and a gradual shift of iron from hepatocytes to the
sinusoidal macrophages (F4/80+). Serum alanine aminotransferase
activity was only mildly increased in Hfe/Nrf2-/- mice, which ﬁts with
the possibility that mild iron overload is insuﬃcient to cause extensive
hepatocellular necrosis/apoptosis. Conversely, necroinﬂammatory foci
of Hfe/Nrf2-/- mice were set locally associated to the presence of
hepatic histiocytes, which may have originated from reticuloendothelial
macrophages (Kupﬀer cells) and/or from circulating monocytes.
Remarkably, these are well-characterized iron-related histological
lesions reported in the livers of human HH patients [17], where
mesenchymal iron deposits are usually not observed until the liver cell
iron content is high enough to cause cell necrosis [1,2]. In middle-aged
and old Hfe/Nrf2-/- animals, the iron-rich macrophages aggregated to
form large siderotic nodules, which were composed of hemosiderin,
lipofuscin and other products of cell degeneration. Erythrocytes ﬂood-
ing areas of parenchymal collapse (as seen in Fig. 5A) may have further
contributed to pigment deposition within hepatic histiocytes upon
phagocytosis. In this etiopathogenic process, HSCs seem to evolve into
myoﬁbroblast-like cells, presumably by the release of factors such as
reactive oxygen species, lipid peroxidation products and transforming
growth factor beta( TGF-β) [23]. α-SMA+ cells are known to be
responsible for collagen overproduction in injured liver areas. In
Hfe/Nrf2-/- animals, collagen bundles were detected in the injured
areas and eventually led to the establishment of hepatic ﬁbrosis in an
age-dependent manner.
The present study describes, for the ﬁrst time, a mouse model of
Fig. 6. Histological evidence of concurrent necroinﬂammation, reticuloendothelial iron loading and ﬁbrosis. (A) HE (left), Perls (center) and Sirius red (right) stains
illustrating concurrent hepatocyte sideronecrosis, iron accumulation in histiocytes and initial pericellular ﬁbrosis, respectively, in young Hfe/Nrf2-/- mice (top images). Arrows point to
hepatocyte apoptotic bodies. Bottom images disclose aggregates of hemosiderin-rich non-hepatocyte cells surrounded by collagen ﬁbers in a middle-aged Hfe/Nrf2-/- mouse.
Bars=50 µm. (B) Sirius red stain for ﬁbrosis and Perls stain for siderosis in the same liver from old Hfe-/- and Hfe/Nrf2-/- mice, representative of N=6–9. Bar=200 µm.
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ﬁbrosis that conveys several features reported in the pathology of
human HH: etiology (chronic iron accumulation), development over
months/years, hepatocellular necrosis/apoptosis, and reticuloendothe-
lial system iron deposits [17,34]. Delima et al. [35] reported increased
collagen deposition in the portal tracts of mice after the simultaneous
disruption of Hfe and another major regulator of iron homeostasis, the
transferrin receptor 2. Also, a recent study reported the development of
hepatic ﬁbrosis in Hamp-/- mice fed an iron-rich diet [36]. In both
studies, however, the eﬀect was attributed to the more severe hepatic
iron loading when compared with single mutant animals or with
animals fed standard diet, respectively. In our model, Hfe/Nrf2-/- mice
appeared to accumulate more liver iron than Hfe-/- single knockouts
(Figs. 3C and 4B). Although the eﬀect did not reach statistical
signiﬁcance, the data suggest a possible role for NRF2 in the regulation
of iron homeostasis that so far has not been reported. On the other
hand, serum iron and transferrin saturation were not signiﬁcantly
elevated in old Hfe/Nrf2-/- mice, which may have possibly resulted
from a number of factors related with old age, including malnutrition,
reduced eﬃciency of iron absorption, and/or chronic inﬂammation
[37]. Nevertheless, ﬁbrosis developed in Hfe/Nrf2-/- mice with con-
centrations of hepatic iron that are ~16-fold below the reported
threshold for the development of hepatic ﬁbrosis in HH patients
[38], and was associated with focal necroinﬂammation. Therefore, it
seems reasonable to assume, based in our study that iron accumulation
(siderosis) per se does not predict the development of liver injury in
our model of human HFE-hemochromatosis, which may also occur in
HH patients; among other factors, oxidative/electrophilic stress seems
to be required.
Excessive iron within hepatocytes catalyzes lipid peroxidation of
cellular organelle membranes to produce reactive aldehydes such as 4-
HNE, which may form aldehyde-protein adducts. Higher amounts of 4-
HNE-protein adducts were previously found in the liver of rats fed an
iron-rich diet [39] and of HH patients [40]. The accumulation of toxic
oxidation products, such as HNE, may cause lysosomal, mitochondrial
and microsomal dysfunction, causing hepatocyte injury or death [2,41].
The livers of Hfe/Nrf2-/- mice disclosed lower basal levels of Nqo1 and
Gsta1 mRNA expression and of glutathione-S-transferase activity.
NQO1 [42,43] and glutathione-S-transferases [44] are involved in the
detoxiﬁcation of reactive molecules, including reactive oxygen species
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Fig. 7. Detection of collagen-producing cells at necroinﬂammatory foci. (A)
Electron micrograph of a sideronecrosis focus in a middle-aged Hfe/Nrf2-/- mouse liver
displaying the accumulation of products of cell degeneration within hepatic phagocytes
(arrows) and the active-type hepatic stellate cells next to collagen bundles (arrowheads
and inset). Bar=5 µm (Inset, 2 µm). (B) Electron micrograph showing hemosiderin (long
arrow)- and lipofuscin-containing residual bodies (small arrow and inset)-rich nodule.
An activated-type stellate cell (star) containing numerous small lipid droplets, expanded
endoplasmic reticulum and extensive extracellular collagen bundles (arrow head) is
depicted nearby a hemosiderin-rich macrophage. Bar=5 µm (Inset, 0.5 µm). (C)
Micrograph depicting the presence of myoﬁbroblasts (α-SMA+) surrounding a cluster
of hepatic macrophages containing autoﬂuorescent material in the liver of a middle-aged
Hfe/Nrf2-/- mouse. Bar=10 µm.
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and a range of harmful electrophiles produced during membrane lipid
peroxidation (e.g. 4-HNE), in the cytosol, mitochondria and endoplas-
mic reticulum. One such mechanism is the conjugation of 4-HNE with
glutathione, which can occur spontaneously or can be catalysed by
glutathione-S-transferases [45,46]. In Nrf2-/- and Hfe/Nrf2-/- livers,
we have observed lower levels of both glutathione and glutathione-S-
transferase activity, which may have contributed to the increased levels
of 4-HNE-protein adducts and of p62/SQSTM1 protein (a surrogate for
the intracellular accumulation of toxic protein aggregates) of the
double-knockouts. These alterations seem to account for the increased
death of Hfe/Nrf2-/- hepatocytes observed in the present study and for
the accumulation of lipofuscin-like autoﬂuorescent storage material
(ceroid) within hepatic phagocytes. Engulfment of dead bodies by
Kupﬀer cells and HSCs increases the expression of proﬁbrogenic
factors, and persistent activation of these cells promotes the develop-
ment of ﬁbrosis [47]. HNE was also reported to up-regulate the
expression of pro-ﬁbrogenic genes (e.g. Col1a1 and Timp1) by hepatic
stellate cell cultures [48]. In this study we established that an increased
susceptibility to oxidative/electrophilic stress boosts the progression
from iron accumulation (siderosis) to liver ﬁbrosis in a model of HH,
and identiﬁed a genetic modiﬁer – the transcription factor NRF2 –
which is a novel factor that seems to play a role (so far never reported)
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in the iron load liver pathogenesis of HH. Our results raise the
possibility that NRF2 status might be a modiﬁer of disease progression
towards iron related liver injury, and that C282Y homozygotes with
compromised NRF2 signaling may be at an increased risk of developing
iron-related hepatic ﬁbrosis or cirrhosis, even with mild increase of
hepatic iron.
In conclusion, we established that the genetic suppression of Nrf2
increases the frequency of iron-related necro-inﬂammatory events
(sideronecrosis) and liver ﬁbrosis in a mouse model of HFE-HH, which
may be due to an increased susceptibility to oxidative/electrophilic
stress. A schematic diagram of the proposed role for NRF2 in limiting
oxidative damage and liver injury in HH, based in our experimental
model, is presented in Fig. 10.
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Fig. 10. Schematic diagram of the working model proposed for NRF2 in limiting oxidative damage and liver injury in HH. In Hfe-/- mice, similar to human HFE-HH,
low hepcidin expression resulted in increased iron absorption and its pericanalicular accumulation within hepatocytes. Macrophages remain iron-depleted. While the genetic disruption
of Nrf2 per se had no signiﬁcant impact on iron homeostasis, the combination of iron overload (Hfe-/-) and compromised antioxidant defences (Nrf2-/-) resulted in lipid peroxidation
and increased number of iron-related necroinﬂammatory lesions (sideronecrosis). The engulfment of dead hepatocytes led to a gradual accumulation of iron within macrophages.
Myoﬁbroblasts recruited towards the injury areas synthesized substantial amounts of collagen ﬁbers involving the liver parenchyma with increased hepatic ﬁbrosis in an age-dependent
manner. The diagram denotes the progressive nature of HFE-HH, where iron accumulation (siderosis) (1st hit) and oxidative stress (2nd hit) are both required for the development of
liver injury.
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